Connection

Justin Stebbing to Cyclophosphamide

Back to Details
This is a "connection" page, showing publications Justin Stebbing has written about Cyclophosphamide.
Justin Stebbing
Connection Strength
0.145
Cyclophosphamide
  1. CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial. Lancet Oncol. 2017 07; 18(7):917-928.
    View in: PubMed
    Score: 0.145
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.